← All organizations
Highest phase reached
Phase 2
First clinical trial
May 31, 2014Last known activity
Feb 28, 2015
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 6 trials)
Phase 2 (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (18)
- NCT02483962Study directorPhase 2Feb 28, 2015
- NCT02467543Lead sponsorPhase 2Feb 28, 2015
- NCT02467543Reponsible party - principal investigatorPhase 2Feb 28, 2015
- NCT02467543Study directorPhase 2Feb 28, 2015
- NCT02483962Lead sponsorPhase 2Feb 28, 2015
- NCT02483962Reponsible party - principal investigatorPhase 2Feb 28, 2015
- NCT02498327Lead sponsorPhase 2Jan 31, 2015
- NCT02498327Study directorPhase 2Jan 31, 2015
- NCT02498327Reponsible party - principal investigatorPhase 2Jan 31, 2015
- NCT02419235Lead sponsorPhase 2Oct 31, 2014
- NCT02419235Reponsible party - principal investigatorPhase 2Oct 31, 2014
- NCT02419235Study directorPhase 2Oct 31, 2014
- NCT02411175Lead sponsorPhase 2Oct 1, 2014
- NCT02411175Reponsible party - principal investigatorPhase 2Oct 1, 2014
- NCT02411175Study directorPhase 2Oct 1, 2014
Details
- Last known activity
- Feb 28, 2015